Astellas Pharma Inc (ALPMF) Q3 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Astellas Pharma Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.664 Thank you very much for your attendance on this Q3 00:00:05.664 -- 00:00:10.676 Y2D FY24 Financial Results Announcement Meeting. 00:00:10.676 -- 00:00:14.881 I'm going to serve as a moderator. I'm 00:00:15.166 -- 00:00:19.555 Chief Communications and IR Officer, Ikeda. 00:00:19.555 -- 00:00:23.786 We make a presentation first, and after that, we'll have a Q&A session. 00:00:23.786 -- 00:00:25.946 The presentation 00:00:26.272 -- 00:00:32.007 is given based upon the presentation material posted on our website, including a Q&A. 00:00:32.007 -- 00:00:36.599 The simultaneous translation for both Japanese and English are provided. 00:00:36.599 -- 00:00:38.103 For 00:00:38.103 -- 00:00:43.376 simultaneous translation, the accuracy cannot be guaranteed by the company. 00:00:43.376 -- 00:00:47.186 You can select the language from Zoom webinar screen menu. 00:00:47.186 -- 00:00:52.400 If you select the original language, then you can hear the original sounds without the 00:00:52.400 -- 00:00:54.790 interpreter's voices. 00:00:54.790 -- 00:00:57.975 This is some disclaimer. 00:00:57.975 -- 00:01:03.244 This material or presentation by representatives for the company and answers and statement 00:01:03.244 -- 00:01:07.492 by representatives for the company in the QA session includes forward-looking statements 00:01:07.492 -- 00:01:12.280 based on assumptions and beliefs in light of the information currently available to management 00:01:12.280 -- 00:01:15.445 as subject to significant risks and uncertainties. 00:01:15.445 -- 00:01:19.973 Actual financial results may differ materially depending on a number of factors. 00:01:19.973 -- 00:01:24.099 They contain information of pharmaceuticals including compounds under development. 00:01:24.099 -- ...